Product Introduction
Pegstim (Pegfilgrastim 6mg) is a biologic medication that plays a crucial role in helping cancer patients undergoing chemotherapy maintain healthy white blood cell levels. Chemotherapy can often lower white blood cell counts, making patients more susceptible to infections. Pegstim helps reduce this risk by stimulating the production of neutrophils, a type of white blood cell essential in fighting infections.
By ensuring a steady supply of white blood cells, Pegstim helps patients undergo chemotherapy with fewer interruptions due to infections, improving their overall experience and treatment outcome. With its long-acting formula, Pegstim is administered via subcutaneous injection once per chemotherapy cycle, providing a convenient option for patients undergoing multiple rounds of treatment.
Uses of Pegstim (Pegfilgrastim 6mg)
Pegstim is primarily indicated for:
- Chemotherapy-Induced Neutropenia – Reduces the risk of infections due to low white blood cell counts caused by chemotherapy.
- Bone Marrow Support – Enhances the production of white blood cells in patients with conditions like leukemia or lymphoma undergoing treatment.
- Post-Chemotherapy Recovery – Speeds up recovery of white blood cell counts following chemotherapy.
By promoting the production of neutrophils, Pegstim reduces the likelihood of infection, allowing patients to maintain their chemotherapy schedules and improving treatment efficiency.
Side Effects of Pegstim (Pegfilgrastim 6mg)
While Pegstim is generally well tolerated, it may cause some side effects. Common side effects may include:
- Bone pain
- Headache
- Nausea
- Fatigue
- Injection site reactions
Less Common Side Effects
In some rare cases, Pegstim may cause more severe side effects such as:
- Spleen rupture
- Allergic reactions
- Shortness of breath
- Chest pain
We are pleased to offer you the healthy.
Pegstim is a vital medication for patients undergoing chemotherapy, providing them with a critical tool to prevent infections during their treatment journey. As part of a comprehensive oncology care plan, Pegstim supports the overall health of patients, ensuring they are better equipped to face the challenges of cancer treatment.
- Pegstim is administered once per chemotherapy cycle via subcutaneous injection.
- Your healthcare provider will guide you on the appropriate injection technique or provide the injection.
- Follow your provider's instructions regarding the timing and dosage of the injection.
- If you miss a dose, contact your healthcare provider for further instructions.
Pegstim works by stimulating the bone marrow to produce more white blood cells, particularly neutrophils. These neutrophils are essential for the body’s immune defense against infections. During chemotherapy, patients are at risk of neutropenia (low white blood cell count), and Pegstim helps restore white blood cell levels to reduce this risk, allowing for a more successful chemotherapy regimen.
- Helps reduce the risk of infection in chemotherapy patients.
- Once-per-cycle administration simplifies treatment.
- Increases the production of white blood cells, particularly neutrophils.
- Improves overall chemotherapy tolerance and reduces the frequency of treatment delays due to infections.
- Pegstim should be used with caution in patients with spleen problems or bone marrow disorders.
- Regular monitoring of blood counts is recommended during treatment.
- Pegstim is not recommended for use in patients with certain allergic reactions to the drug.
- Consult your doctor if you experience severe side effects like bone pain or breathing issues.